There is no end in sight, with the Covid vaxxes being the test run of a new vax culture of mRNA gene therapies. A vax is underway for influenza, with clinical trials getting underway. Moderna has a new vax which it claims protects against both Covid-19 and influenza. Dr Robert Malone, who has patents on aspects of the mRNA platform lists these main concerns, by way of summary: “That the use of pseudouridine has been given the green light again, without further preclinical testing on safety. That the length of time the mRNA continues to make protein once in the body and levels of protein expressed over time has not been assessed in an animal body prior to the onset of these trials. This is shocking.
It appears that the FDA also did not require more testing of the nano lipid particles for safety, reproductive toxicity and bio-distribution in an animal model. This assumption is again based on the short timeline to clinical trial for these products.